• Avalo Therapeutics granted an inducement stock option covering 34,000 common shares to a new employee on May 21, 2026.
• The option exercise price was set at $16.6 per share, matching the stock’s closing price on the grant date.
• Vesting starts with 25% on the first anniversary of the employee’s start date, with the remainder vesting monthly over the next 36 months, subject to continued service.
• The award was issued under the company’s 2025 Inducement Award Plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalo Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605221601PRIMZONEFULLFEED9725435) on May 22, 2026, and is solely responsible for the information contained therein.